PetVivo Holdings Inc
Change company Symbol lookup
Select an option...
PETV PetVivo Holdings Inc
TFPM Triple Flag Precious Metals Corp
SCLXW Scilex Holding Equity Warrants Exp 11th Oct 2027 *W EXP 10/11/2027
GMBL Esports Entertainment Group Inc
CFRX ContraFect Corp
AAL American Airlines Group Inc
NVDA NVIDIA Corp
AMD Advanced Micro Devices Inc
QQQ Invesco QQQ Trust
AAPL Apple Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

PetVivo Holdings, Inc. is a development-stage company. The Company is a biomedical device company focused on licensing and commercialization of medical devices and therapeutics for pets. The Company's operating subsidiary, PetVivo, Inc., (PetVivo) is engaged in the business of acquiring/in-licensing and adapting human biomedical technology and products for commercial sale in the veterinary market to treat pets and other animals suffering from arthritis and other painful affliction. As of March 31, 2015, PetVivo's pipeline included 17 therapeutic devices for both veterinary and human clinical applications. PetVivo's pipeline includes VD-01, VD-02 and VD-06, which are indicated for osteoarthritis, and VD-04, which is indicated for urinary incontinence, among others. Its subsidiary also includes Gel-Del Technologies, Inc., which has completed a pivotal clinical trial using their thermoplastic biomaterial as a dermal filler for human cosmetic applications.

Closing Price
$2.55
Day's Change
0.2126 (9.08%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.56
Day's Low
2.31
Volume
(Heavy Day)
Volume:
27,700

10-day average volume:
18,442
27,700

Company Profile

PetVivo Holdings, Inc. is a development-stage company. The Company is a biomedical device company focused on licensing and commercialization of medical devices and therapeutics for pets. The Company's operating subsidiary, PetVivo, Inc., (PetVivo) is engaged in the business of acquiring/in-licensing and adapting human biomedical technology and products for commercial sale in the veterinary market to treat pets and other animals suffering from arthritis and other painful affliction. As of March 31, 2015, PetVivo's pipeline included 17 therapeutic devices for both veterinary and human clinical applications. PetVivo's pipeline includes VD-01, VD-02 and VD-06, which are indicated for osteoarthritis, and VD-04, which is indicated for urinary incontinence, among others. Its subsidiary also includes Gel-Del Technologies, Inc., which has completed a pivotal clinical trial using their thermoplastic biomaterial as a dermal filler for human cosmetic applications.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
67.12x
Price/Book (MRQ)
9.22x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

January 2023
Current Month
143.1K
Previous Month
160.4K
Percent of Float
2.06%
Days to Cover
8.2348 Days

Share Information

PETV is in a share class of common stock
Float
6.0M
Shares Outstanding
11.1M
Institutions Holding Shares
14
5.05%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Gregory D. Cash
  • John LaiPres.
  • Robert J. FolkesCFO
  • Randall A. MeyerCOO
  • John Fitzgerald Dolan

Address

  • 5251 Edina Industrial Blvd
  • Edina, MN 55439
  • Phone: (952) 217-4952
  • Fax: (775) 884-9383
  • https://petvivo.com/

Insider Trading

During the most recent quarter, 22K shares were bought in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.